EX-21.1 7 ahpa-20220416xex21d1.htm EXHIBIT-21.1

Exhibit 21.1

List of Principal Subsidiaries of OmniAb, Inc.

In connection with the separation of OmniAb, Inc. from Ligand Pharmaceuticals Incorporated, the following entities will become wholly owned subsidiaries of OmniAb, Inc.

Wholly Owned Subsidiary

   

Place of Incorporation

Ab Initio Biotherapeutics, Inc.

Delaware

Crystal Bioscience, Inc.

California

Icagen, LLC

Delaware

Taurus Biosciences, LLC

Delaware

xCella Biosciences, Inc.

Delaware